europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Library
Become a member
✕

SwiftPharma joins EuropaBio: pioneering sustainable, scalable and affordable plant-made therapeutic proteins

16/01/2023
PRESS RELEASE

Brussels, 16 January 2023 – EuropaBio is pleased to announce that SwiftPharma has joined the association as a Corporate SME.

SwiftPharma is a biotech start-up, focused on the Research & Development of next generation biologics. It is specialised in plant-made biologics, using molecular farming and a data-driven approach to design and produce next-generation proteins. According to SwiftPharma, their plants produce vaccines, antibodies, cytokines, enzymes and other high-value, animal-free proteins that re-define safety and sustainability.

As a member of EuropaBio, SwiftPharma aims to be actively involved across sectors and a valued SME contributor to the recently launched EuropaBio Biomanufacturing Platform.

EuropaBio Director-General Dr. Claire Skentelbery commented “next generation biomanufacturing by SMEs is exactly the route that Europe must take and SwiftPharma demonstrates how we can be competitive, agile and resilient across sectors. We are delighted to bring the voice of SwiftPharma into our advocacy for biotechnology in Europe.”

Jeroen Hofenk, SwiftPharma Founder and CSO added: “We are very excited about being included into the EuropaBio family. Our company mission closely aligns with that of EuropaBio by focusing on technologies that improve the diagnosing, treatment, prevention, and ultimately the curing of diseases. Our technology has the potential to improve existing products by making them safer, less expensive, and with unlimited scalability. Just as importantly the SwiftPharma platform provides opportunities for new products and innovation that can have a major impact in a multitude of sectors”.

 

SwiftPharma joins EuropaBio

SwiftPharma joins EuropaBio: pioneering sustainable, scalable and affordable plant-made therapeutic proteins


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

17/01/2023

EuropaBio launches SME BioForum in Rare Diseases


Read more
17/01/2023

EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform


Read more
19/12/2022

EuropaBio sat down with new member Association of Biotechnological Companies Bioforum, to find out how they champion biotech in central and eastern Europe


Read more
19/12/2022

The Association of Biotechnological Companies Bioforum joins EuropaBio: representing Polish biotech at European legislative fora and involving Polish companies in the debate about the future of the industry


Read more

Important links

  • EuropaBio launches SME BioForum in Rare Diseases
  • EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform

Categories in our Newsroom

Search by tags

  • Innovation
  • Excellence
  • Science
  • ATMPs
  • Healthcare Biotech
  • Industrial Biotech
  • Investment
  • EuropaBio
  • EFIB
  • Regulation
  • Rare Diseases
  • COVID-19
  • Members
  • Cancer
  • Patients
  • Patient BioForum
  • Gene & Cell Therapies
  • Accessibility
  • Intellectual Property
  • Pharmaceutical Strategy for Europe

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies